Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
General information on the health of the subject and persistence of the cellular and humoral immune responses to study vaccination will be evaluated.
Age
18–55
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
All subjects must satisfy ALL the following criteria at study entry:
HIV-infected subject.
Previous participation in a study evaluating GSK HIV vaccine 732462.
Written informed consent obtained from the subject.
You may not be if
The following criteria should be checked at the time of study entry. If ANY exclusion criterion applies, the subject must not be included in the study:
Subjects who did not receive a complete vaccination course in previous studies.
